Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-29

FDA Approved: PSEUDOEPHEDRINE HYDROCHLORIDE — Original Application (WALGREEN CO.)

View source ↗

Summary

FDA approved Walgreens' original application for pseudoephedrine hydrochloride as a generic drug, enabling market authorization for this decongestant product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PSEUDOEPHEDRINE HYDROCHLORIDE (Pseudoephedrine hydrochloride)

Snippet

ORIG AP for PSEUDOEPHEDRINE HYDROCHLORIDE (PSEUDOEPHEDRINE HYDROCHLORIDE)